ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Implementation of an integrative safety consultation service for the use of dietary and herbal supplements among patients with hematological diseases.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDietary and herbal supplements (DHS) are used by 30% of hematological patients despite safety concerns. A service of integrative safety consultations was implemented in the Hematological Institute of Bnai Zion Medical Center. This study examines the effect of such consultation on DHS safety in hematologic patients.
methodsPatients from the Hematological Institute were referred to the "integrative safety consultation team." The naturopath recommended DHS according to symptoms disclosed, and safety analysis was performed by the clinical pharmacist. Symptom and side effect assessment was repeated in each follow-up visit to evaluate DHS safety.
resultsBetween 2021 and 2024, 42 patients were included. Twenty-eight (67%) used DHS before the consultation. Employed patients were more likely to use DHS (p = 0.02). A total of 176 potential interactions were described in 30 patients. Most interactions were theoretical (45%), with a pharmacodynamic additive mechanism (59%), involving herbs (82%) and antihypertensives (26%) or anticoagulants (23%). One side effect was disclosed following Hericium prescription to a patient that developed leg edema and neuropathic pain exacerbation (probable causality according to the Naranjo scale and FDA algorithm). Patients' concerns improved from the first to the second visit. In 21% of the patients who used DHS before the consultation, DHS was documented in the medical chart by the time of first consultation, all of them pertaining to vitamins or minerals.
conclusionConsideration of DHS in the management of patients with hematological conditions requires a systematic and comprehensive process to ensure patient safety and wellbeing. An integrative safety naturopathic-pharmacologic consultation can address such needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.